ArticleDiabetes & metabolism journal2023

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists.

Tzu-Yi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.